Loading...
SNSE SENSEI BIOTHERAPEUTICS INC US FDA Inspections 8-K Filing
Back
SNS
SNS
SENSEI BIOTHERAPEUTICS INC
(SNSE)
Follow
FY2025 8 K
View More
Back
SNS
SNS
SENSEI BIOTHERAPEUTICS INC
(SNSE)
Follow
FY2025 8 K
Filing:
8 K
Published on:
27 Mar '25
Financial Results
28 Mar '25
Clinical Trial Update
27 Mar '25
Stock Delisting Notice
7 Jan '25
Financial Results
14 Nov '24
Board Resignation
30 Oct '24
Management Change
20 Sep '24
Earnings Reports
6 Aug '24
Delisting
12 Jul '24
Resignation of Director
27 Jun '24
Annual Meeting
13 Jun '24
Presentation Update
3 Jun '24
Clinical Data Presentation
23 May '24
Financial Results Announcement
9 May '24
Consulting Agreement with F...
12 Apr '24
Resignation of CFO
2 Apr '24
Stockholder Rights Agreemen...
5 Mar '24
Financial Results Announcement
28 Feb '24
Resignation and Appointment
8 Feb '24
Presentation Update
4 Jan '24
Financial Results Announcement
7 Nov '23
Rejection of Proposal
6 Nov '23
Clinical Data and Presentat...
3 Nov '23
Delisting
20 Oct '23
Earnings Report
3 Aug '23
Investor Conferences
27 Jun '23
Amendment to Rights Agreement
23 Jun '23
Purchase Agreement for Stoc...
23 May '23
Earnings Reports
9 May '23
Presentation Update
20 Apr '23
Earnings Reports
28 Mar '23
Presentation Update
13 Mar '23
Nomination of Board Candidates
10 Mar '23
Stockholder Rights Plan
7 Mar '23
Bonuses paid in RSUs
6 Feb '23
External Links:
SEC
AI Assistant
Close
SENSEI BIOTHERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.